JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1751
Macy's
M
$5.88B
| $14.5M | ﹤0.01% |
675,453
-121,843
| -15% | -$2.77M |
2013 Q2
24 quarters
|
|
1752
Fox Class B
FOX
$23.9B
| $14.5M | ﹤0.01% |
406,713
+6,791
| +2% | +$246K |
2019 Q1
1 quarter
|
|
1753
PUT
PepsiCo
PEP
$171B
| $14.5M | ﹤0.01% |
110,300
+65,000
| +143% | +$8.33M |
2018 Q2
4 quarters
|
|
|
CNH
1754
CNH Industrial
CNH
$21.4B
| $14.5M | ﹤0.01% |
1,622,147
-597,556
| -27% | -$5.2M |
2013 Q4
22 quarters
|
|
|
AVTA
1755
DELISTED
Avantax, Inc. Common Stock
AVTA
| $14.5M | ﹤0.01% |
494,921
-1,818
| -0.4% | -$59.8K |
2013 Q2
24 quarters
|
|
1756
PUT
Costco
COST
$409B
| $14.5M | ﹤0.01% |
54,600
-16,200
| -23% | -$4.04M |
2017 Q1
9 quarters
|
|
1757
Crane NXT
CXT
$2.83B
| $14.5M | ﹤0.01% |
510,553
-152,086
| -23% | -$4.43M |
2013 Q2
24 quarters
|
|
|
ALXN
1758
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $14.5M | ﹤0.01% |
114,900
+39,800
| +53% | +$5.13M |
2017 Q1
9 quarters
|
|
1759
CALL
Edwards Lifesciences
EW
$50.3B
| $14.5M | ﹤0.01% |
234,000
-127,200
| -35% | -$7.69M |
2018 Q4
2 quarters
|
|
1760
First Trust Value Line Dividend Fund
FVD
$7.59B
| $14.4M | ﹤0.01% |
431,173
+313,487
| +266% | +$10.4M |
2015 Q1
17 quarters
|
|
|
SFLY
1761
DELISTED
Shutterfly, Inc.
SFLY
| $14.4M | ﹤0.01% |
285,003
+275,286
| +2,833% | +$12.6M |
2015 Q4
14 quarters
|
|
|
TGP
1762
DELISTED
Teekay LNG Partners L.P.
TGP
| $14.4M | ﹤0.01% |
1,037,495
-445,874
| -30% | -$6.36M |
2013 Q2
24 quarters
|
|
1763
Community Bank
CBU
$3.16B
| $14.3M | ﹤0.01% |
220,366
+8,514
| +4% | +$545K |
2013 Q2
24 quarters
|
|
1764
PUT
TSMC
TSM
$2.52T
| $14.3M | ﹤0.01% |
362,000
+16,800
| +5% | +$692K |
2018 Q2
4 quarters
|
|
1765
iShares MSCI China A ETF
CNYA
$197M
| $14.3M | ﹤0.01% |
+503,591
| New | +$14.4M |
2019 Q2
0 quarters
|
|
1766
Hanmi Financial
HAFC
$934M
| $14.3M | ﹤0.01% |
650,436
-17,034
| -3% | -$378K |
2013 Q2
24 quarters
|
|
1767
Telecom Argentina
TEO
$5.39B
| $14.2M | ﹤0.01% |
822,050
-148,749
| -15% | -$2.27M |
2014 Q1
21 quarters
|
|
1768
CALL
Enbridge
ENB
$103B
| $14.2M | ﹤0.01% |
+400,000
| New | +$14.6M |
2019 Q2
0 quarters
|
|
1769
Liberty Latin America Class A
LILA
$1.73B
| $14.2M | ﹤0.01% |
1,284,572
-13,550
| -1% | -$166K |
2015 Q4
14 quarters
|
|
1770
Nice
NICE
$6.79B
| $14.2M | ﹤0.01% |
103,526
-23,914
| -19% | -$3.23M |
2015 Q1
17 quarters
|
|
1771
Stepan Co
SCL
$1.43B
| $14.2M | ﹤0.01% |
157,776
+3,898
| +3% | +$348K |
2013 Q2
24 quarters
|
|
|
ARRY
1772
CALL
DELISTED
Array Biopharma Inc
ARRY
| $14.1M | ﹤0.01% |
306,100
-45,300
| -13% | -$1.27M |
2018 Q4
2 quarters
|
|
1773
Annaly Capital Management
NLY
$13.8B
| $14.1M | ﹤0.01% |
387,985
+51,415
| +15% | +$1.96M |
2013 Q2
24 quarters
|
|
1774
PUT
Honeywell
HON
$67.9B
| $14.1M | ﹤0.01% |
85,941
+45,623
| +113% | +$7.26M |
2016 Q2
12 quarters
|
|
1775
Synaptics
SYNA
$4.75B
| $14M | ﹤0.01% |
478,574
-200,765
| -30% | -$6.55M |
2013 Q2
24 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.